Distribution and Pharma Market Access in Israel.
your product. our efforts.
Pharma Market Access in Israel.
your product. our efforts.
Final date for submissions is March 1st, each year. If you consider applying – NOW is the time. CONTACT US FOR FREE CONSULTATION
The Market Access arena in Israel in highly regulated, involving lots of stakeholders. The Health Reimbursement Process in Israel is a once-per-year process, taking place in Q4 of each calendar year. Only 10%-15% of HTAs submitted are reimbursed. Each year, 172M US$ are allocated, so the competition is high.
IMS IL Ltd.™ holds a recognized success rate of 74% reimbursement.
You need a professional and dedicated expert team to ensure success.
YOUR PRODUCT, OUR EFFORTS.
IMS IL Ltd. is a boutique Distribution, Market Access and Medical Affairs firm, leaded by Baruch Weinreb, MD.
Dr. Weinreb is board certified in Internal Medicine and Medical Education. He served for 12 years as a senior physician in one of the largest hospitals in Israel followed by 21 years with the Pharma industry. Among his roles with the industry, he served as Medical Director for Pfizer, Merck and BMS and later as Market Access Lead for BMS in Israel
Sharon Bar Dayan – Chief Commercial Officer
Highly experienced in the multinational pharmaceutical business. Main competency in business
managing, sales, marketing and market access. Strategist, curious, leader, team player and mission
driven.
CONTACT US
© 2022 ALL RIGHTS RESREVED
Copyright by BWeinreb Medical Market Access Consulting
